Cargando…

Correction: Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells tocancer-associated fibroblasts

Detalles Bibliográficos
Autores principales: Zhou, Yuan, Ren, Haozhen, Dai, Bo, Li, Jun, Shang, Longcheng, Huang, Jianfei, Shi, Xiaolei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793507/
https://www.ncbi.nlm.nih.gov/pubmed/36575457
http://dx.doi.org/10.1186/s13046-022-02575-z
_version_ 1784859858587090944
author Zhou, Yuan
Ren, Haozhen
Dai, Bo
Li, Jun
Shang, Longcheng
Huang, Jianfei
Shi, Xiaolei
author_facet Zhou, Yuan
Ren, Haozhen
Dai, Bo
Li, Jun
Shang, Longcheng
Huang, Jianfei
Shi, Xiaolei
author_sort Zhou, Yuan
collection PubMed
description
format Online
Article
Text
id pubmed-9793507
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97935072022-12-28 Correction: Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells tocancer-associated fibroblasts Zhou, Yuan Ren, Haozhen Dai, Bo Li, Jun Shang, Longcheng Huang, Jianfei Shi, Xiaolei J Exp Clin Cancer Res Correction BioMed Central 2022-12-27 /pmc/articles/PMC9793507/ /pubmed/36575457 http://dx.doi.org/10.1186/s13046-022-02575-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Zhou, Yuan
Ren, Haozhen
Dai, Bo
Li, Jun
Shang, Longcheng
Huang, Jianfei
Shi, Xiaolei
Correction: Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells tocancer-associated fibroblasts
title Correction: Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells tocancer-associated fibroblasts
title_full Correction: Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells tocancer-associated fibroblasts
title_fullStr Correction: Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells tocancer-associated fibroblasts
title_full_unstemmed Correction: Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells tocancer-associated fibroblasts
title_short Correction: Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells tocancer-associated fibroblasts
title_sort correction: hepatocellular carcinoma-derived exosomal mirna-21 contributes to tumor progression by converting hepatocyte stellate cells tocancer-associated fibroblasts
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793507/
https://www.ncbi.nlm.nih.gov/pubmed/36575457
http://dx.doi.org/10.1186/s13046-022-02575-z
work_keys_str_mv AT zhouyuan correctionhepatocellularcarcinomaderivedexosomalmirna21contributestotumorprogressionbyconvertinghepatocytestellatecellstocancerassociatedfibroblasts
AT renhaozhen correctionhepatocellularcarcinomaderivedexosomalmirna21contributestotumorprogressionbyconvertinghepatocytestellatecellstocancerassociatedfibroblasts
AT daibo correctionhepatocellularcarcinomaderivedexosomalmirna21contributestotumorprogressionbyconvertinghepatocytestellatecellstocancerassociatedfibroblasts
AT lijun correctionhepatocellularcarcinomaderivedexosomalmirna21contributestotumorprogressionbyconvertinghepatocytestellatecellstocancerassociatedfibroblasts
AT shanglongcheng correctionhepatocellularcarcinomaderivedexosomalmirna21contributestotumorprogressionbyconvertinghepatocytestellatecellstocancerassociatedfibroblasts
AT huangjianfei correctionhepatocellularcarcinomaderivedexosomalmirna21contributestotumorprogressionbyconvertinghepatocytestellatecellstocancerassociatedfibroblasts
AT shixiaolei correctionhepatocellularcarcinomaderivedexosomalmirna21contributestotumorprogressionbyconvertinghepatocytestellatecellstocancerassociatedfibroblasts